About IMCD
IMCD is a company based in Rotterdam (Netherlands) founded in 1995 was acquired by Abn Amro in July 2005. The company has 5,130 employees as of December 31, 2024. IMCD has completed 52 acquisitions, including ACM AB, Addpol Chemspecialities and Andes Chem. IMCD offers products and services including Specialty Chemicals and Ingredients.
- Headquarter Rotterdam, Netherlands
- Employees 5130 as on 31 Dec, 2024
- Stage Public
-
Sectors
Consumer
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imcd N.V.
-
Annual Revenue
$4.91 B (USD)6.41as on Dec 31, 2024
-
Net Profit
$289.06 M (USD)-4.8as on Dec 31, 2024
-
EBITDA
$574.8 M (USD)5.11as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
5130
as on Dec 31, 2024
-
Investments & Acquisitions
ACM AB
& 51 more
-
Acquired by
Abn Amro
(Jul 15, 2005)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of IMCD
IMCD is a publicly listed company on the EURONEXT with ticker symbol IMCD in Netherlands, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of IMCD
IMCD offers a comprehensive portfolio of products and services, including Specialty Chemicals and Ingredients.
Specialty chemicals are distributed for use in industrial and manufacturing processes
Ingredients for food and pharmaceuticals are supplied through established networks
People of IMCD
Unlock access to complete
Funding Insights of IMCD
Investors in IMCD
IMCD has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ABN AMRO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
ABN AMRO is recognized as a personal bank in the digital era.
|
Locked | Locked | Locked |
Investor details for IMCD
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IMCD
IMCD has strategically engaged in corporate development activities, having acquired 52 companies. Notable acquisitions include ACM AB, Addpol Chemspecialities and Andes Chem.
Investment portfolio details for IMCD
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical products are distributed by DCS Pharma in Switzerland.
|
Locked | Locked | 2016 | Locked | |
|
Natural body care products are offered by the O&3 brand.
|
Locked | Locked | 2014 | Locked | |
|
Manufacturing of pharmaceutical products is conducted by COBAPHARMA.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for IMCD
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - IMCD
Detailed financials for IMCD
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imcd Comparisons
Peer comparison for IMCD
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IMCD
Detailed competitors of IMCD
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imcd
Complete news archive for IMCD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IMCD
IMCD was founded in 1995 and raised its 1st funding round 20 years after it was founded.
IMCD is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.
Piet Slikke is the current CEO of IMCD.
As of Dec 31, 2024, the latest employee count at IMCD is 5,130.
Annual revenue of IMCD is $4.91B as on Dec 31, 2024.
IMCD was established in 1995 in Rotterdam, Netherlands, as a distributor in the chemicals and food sectors. Operations are centered on sourcing and supplying speciality chemicals and ingredients to industries worldwide. Services include market expertise, technical support, and logistics management. The company is headquartered in Rotterdam, with a global network supporting clients in Europe, Asia, and the Americas. Leadership is provided by CEO Piet Slikke.
IMCD offers Specialty Chemicals and Ingredients.
Yes, IMCD is publicly traded on EURONEXT under the ticker symbol IMCD.
IMCD has made 52 acquisitions, including ACM AB, Addpol Chemspecialities, and Andes Chem.
IMCD has 1 investor. Key investors include ABN AMRO.
The ticker symbol of IMCD is IMCD on EURONEXT.